November 19, 2024Open Access

Evaluating the cost, cost-effectiveness and survival of an eHealth-facilitated integrated care model for allogeneic stem cell transplantation: Results of the German SMILe randomized, controlled implementation science trial

Key Points

Key points are not available for this paper at this time.

Abstract

The SMILe-ICM appears to offer survival and rehospitalization benefits, particularly for vulnerable groups, e.g., patients living alone. Larger, adequately powered studies are needed to validate these findings.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Lynn Leppla

Klaus Kaier

Anja Schmid

Journals

European Journal of Oncology Nursing

Actions

Institutions

University of Freiburg

University of Basel

University Hospital of Basel

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Evaluating the cost, cost-effectiveness and survival of an eHealth-facilitated integrated care model for allogeneic stem cell transplantation: Results of the German SMILe randomized, controlled implementation science trial

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study